Position in NERV
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$30,807,174
+$9,212,639 QoQ
Shares Held
5,113,224
-4.8% QoQ
Ownership
11.0%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FEDERATED HERMES, INC. holds $2,358,506,481 across 147 Biotechnology names. NERV ranks #29 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
687,816 | $227,577,679 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
254,946 | $196,981,475 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,286,303 | $111,869,771 | |
| 4 | MRNA |
Moderna, Inc.
|
1,977,079 | $100,435,613 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
2,987,107 | $99,530,405 | |
| 6 | INSM |
INSMED Inc
|
538,257 | $88,015,784 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
2,049,439 | $81,403,717 | |
| 8 | EYPT |
EyePoint, Inc.
|
5,669,589 | $73,081,000 |
All Filings in NERV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,234,639 | 8,690,926 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $30,807,174 | 5,113,224 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $21,594,535 | 5,371,775 | Shares | Defined | 2026-02-12 | |
| 2025-12-22 | $37,381,254 | 9,392,275 | Shares | Sole | 2025-12-29 | |
| 2025-10-21 | $8,661,672 | 1,351,275 | Shares | Sole | 2025-10-28 | |
| 2025-09-30 | $2,844,433 | 1,351,275 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,324,193 | 1,351,275 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,297,167 | 1,351,275 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $3,002,533 | 1,351,275 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,607,904 | 1,351,275 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,310,567 | 1,351,275 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $3,486,289 | 1,351,275 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,310,341 | 1,351,275 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $9,323,797 | 1,351,275 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,350,653 | 1,351,275 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,922,040 | 1,201,275 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $1,910,027 | 1,201,275 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,087,768 | 1,201,275 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,976,220 | 1,201,275 | Shares | Defined | 2022-09-16 | |
| No filing history on record for this holder in this stock. | ||||||